Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
出版年份 2023 全文链接
标题
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-11-06
DOI
10.3389/fphar.2023.1245642
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study
- (2023) Adam Goldman et al. Cardiovascular Diabetology
- Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
- (2022) Raymond Li et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
- (2022) Gabriella di Mauro et al. Pharmaceuticals
- SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study
- (2022) Celestino Sardu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
- (2022) Annamaria Mascolo et al. Frontiers in Cardiovascular Medicine
- Managing older patients with heart failure calls for a holistic approach
- (2021) Julia H.I. Wiersinga et al. ESC Heart Failure
- Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States
- (2021) Veer Sangha et al. Circulation-Cardiovascular Quality and Outcomes
- Current and future therapeutic perspective in chronic heart failure
- (2021) Annamaria Mascolo et al. PHARMACOLOGICAL RESEARCH
- SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies
- (2021) Annamaria Mascolo et al. PHARMACOLOGICAL RESEARCH
- Association of Sodium-Glucose Cotransporter–2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
- (2021) Min Zhuo et al. JAMA Network Open
- Impact of an early mobilization protocol on outcomes in trauma patients admitted to the intensive care unit
- (2020) Sherry Jenna Coles et al. Journal of Trauma and Acute Care Surgery
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study
- (2020) Bin Zhao et al. Journal of Diabetes Investigation
- Fracture Risk After Initiation of Use of Canagliflozin
- (2019) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk
- (2019) Yangli Ye et al. Frontiers in Pharmacology
- Hypertension Management in Older and Frail Older Patients
- (2019) Athanase Benetos et al. CIRCULATION RESEARCH
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
- (2019) Jiahua Li et al. Clinical Kidney Journal
- Sodium‐glucose co‐transporter 2 inhibitors and the risk of fractures: A propensity score‐matched cohort study
- (2019) Sruthi Adimadhyam et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
- (2019) Katrine Hygum et al. BONE
- Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
- (2018) Wen-Hsuan Hou et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Adverse effects of SGLT2 inhibitors on bone health
- (2018) Jenny E. Blau et al. Nature Reviews Nephrology
- Diabetes pharmacotherapy and effects on the musculoskeletal system
- (2018) Evangelia Kalaitzoglou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
- (2018) Peter Ueda et al. BMJ-British Medical Journal
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
- (2016) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Association of Cardiovascular Disorders and Falls: A Systematic Review
- (2016) Sofie Jansen et al. Journal of the American Medical Directors Association
- Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial
- (2015) Ofri Mosenzon et al. DIABETES CARE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
- (2014) Bruce Neal et al. DIABETES CARE
- Morbus Diureticus in the Elderly: Epidemic Overuse of a Widely Applied Group of Drugs
- (2013) Martin Wehling Journal of the American Medical Directors Association
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
- (2013) Donald E. Kohan et al. KIDNEY INTERNATIONAL
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Risk Factors for Falls in Community-dwelling Older People
- (2010) Silvia Deandrea et al. EPIDEMIOLOGY
- Falls: Epidemiology, pathophysiology, and relationship to fracture
- (2008) Sarah D. Berry et al. Current Osteoporosis Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now